Improving the quality of human health

Clinical Laboratory Services | Innovative Biomarker and Bioanalytical Solutions

About Synexa Life Sciences

Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of 150 across five global laboratory locations; Cape Town, London, Berlin, Turku (Finland) and Rockville (Maryland USA), we provide innovative solutions to support our customers to achieve their clinical milestones. 

Our main areas of expertise include biomarker identification and development, clinical bioanalysis, soluble biomarker analysis (utilising MSD, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies.

Services

ProtoTrials®

ProtoTrials® is a proprietary human in vitro translational platform. ProtoTrials studies are adaptive and collaborative in nature and draw together vast scientific expertise, an extensive selection of technologies and customisable assays, along with access to a broad portfolio of samples from both healthy and diseased states.

Flow Cytometry

Flow Cytometry is core to Synexa’s positioning as a biomarker expert. We provide key expertise in the development and validation of complex assays, encompassing multimer staining, phospho-flow and target engagement assays.

Soluble
Biomarkers

With decades of experience in biomarker strategies and assay development, our biomarker panels enhance decision-making in all stages of therapeutic clinical development.

Bioanalysis

We offer extensive experience in large molecule bioanalysis, developing and fully validating bespoke assays to support clinical sample analysis.

Tissue Imaging

Synexa’s specialised tissue and cell imaging services allow for the interrogation of multiple targets in situ. Leveraging cutting edge technologies, we provide comprehensive and precise insights into spatial relationships in cells and tissues.

Biomarker
Consulting

Leverage our expert team of in-house scientists to develop and implement optimal biomarker strategies. Integrative biomarker panels will provide crucial insights, improving the decision making process throughout clinical development of a therapeutic.

Expertise

Synexa specialises in biomarker and bioanalytical services which can be specifically tailored to suit both the modality of the therapeutic and the disease area of focus. Autoimmune conditions are highly heterogenous, affecting numerous cell types, molecular pathways and tissues, necessitating multi-pronged approaches integrating technology platforms including targeted genetic analysis, soluble biomarkers and flow cytometry.

Synexa’s expertise in the field of immunology and immune-based analytical technologies makes us the perfect partner in advancing oncology therapeutic pipelines. We use innovative approaches and validated platforms to answer client-specific questions for quality, clinically-relevant data.

Accelerate vaccine development and evaluation with our comprehensive suite of bioanalytical services, supporting safety, immunogenicity, and efficacy assessments for a wide range of vaccine candidates.

Advanced bioanalytical solutions for cell and gene therapies, providing comprehensive characterization, quantification, and safety assessment to support the development of innovative treatment approaches.
Robust analytical solutions for biosimilar development, offering comparative bioanalysis, potency assays, and structural characterization to ensure similarity to reference biologics and meet regulatory requirements.

Bridging the gap between science and life.

Discuss real solutions to develop your therapeutic pipeline.

Latest Insights